Ryan Barnes
Orthopaedic Surgery · Prince George, VANPI 1194259960
Payments from drug & device makers
Across 80 payments — averaging $575.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$19K
- Stryker$3K
- Vericel Corporation$2K
- Southtech Orthopedics$1K
- Johnson & Johnson$216
- plus $911 from 17 others
What the payments were for
- Speaking & faculty fees$1,5003%
- Grants$20,00043%
- Travel & lodging$1,5983%
- Food & beverage$3,5278%
- Education$19,42542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $20,000 |
| Smith+Nephew | 13 | $19,167 |
| Stryker | 31 | $2,651 |
| Vericel Corporation | 4 | $1,905 |
| Southtech Orthopedics | 1 | $1,200 |
| Johnson & Johnson | 7 | $216 |
| Fortis Surgical, LLC | 6 | $198 |
| Calyxo, Inc. | 1 | $147 |
| Zimmer Biomet | 1 | $120 |
| Profound Medical Corp. | 2 | $94 |
| Anika Therapeutics, Inc. | 1 | $53 |
| Inspire Medical Systems, Inc. | 1 | $47 |
| Urogen Pharma, Inc. | 1 | $36 |
| Shoulder Innovations, Inc. | 1 | $30 |
| Boston Scientific | 1 | $27 |
| Tempus AI, Inc | 1 | $26 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Moximed, Inc | 1 | $22 |
| Blue Earth Diagnostics | 1 | $19 |
| Pfizer | 1 | $18 |
| Linvatec Corporation | 1 | $16 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,050 in reported general payments places this provider in the 85th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 53 | $323 |
| Diclofenac Sodium | 21 | $240 |
| Oxycodone Hcl | 39 | $237 |
| Meloxicam | 120 | $227 |
| Ondansetron Hcl | 23 | $205 |
| Gabapentin | 14 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Prince George
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.5M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- Randall PeytonSterling$2.9M
- William MihalkoCharlottesville$2.1M
- David MillerNorth Chesterfield$1.8M
- Keith LawhornFairfax$1.8M
- Joshua HerzogNorth Chesterfield$1.5M
- Joseph GonduskyVirginia Beach$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.